Menu
← Oncology Approval Tracker
FDA DECISION ·
Bendamustine (Treanda first generics)
bendamustine hydrochloride · Accord Healthcare and Dr. Reddy’s Laboratories
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
First generic vial products for CLL or indolent B-cell non-Hodgkin lymphoma that progressed during or within six months after rituximab-based treatment.
LAMPGEN ANALYSIS
Why it matters
The approvals add generic powder-for-injection products for established hematology indications.
What research teams should watch
Use product-specific preparation instructions and document prior rituximab timing for the lymphoma indication.
PRIMARY RECORDS